Miguel Hernandez Pampaloni, MD, PhD

Title(s)Professor, Radiology
SchoolSchool of Medicine
Address505 Parnassus Avenue, #L308A
San Francisco CA 94117
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Universidad ComplutenseM.D.1991School of Medicine
    Collapse Awards and Honors
    Society of Nuclear Medicine Meeting2002Cardiovascular Young Investigator Award
    Spanish Society of Cardiology Annual Meeting1999Best Communication Award

    Collapse Overview 
    Collapse Overview
    Miguel Hernandez Pampaloni, MD, PhD, is the Director of Nuclear Cardiology for the Molecular Imaging and Therapeutics Clinical Section in the Department of Radiology and Biomedical Imaging at the University of California, San Francisco. Dr. Pampaloni is responsible for overseeing nuclear cardiology and development of new techniques to evaluate cardiac metabolism and function. He will also serve as co-chair of the Cancer Center's new Molecular Imaging & Radionuclide Therapy Site Committee. Dr. Pampaloni earned his PhD in Radiological Sciences from the Universidad Complutense School of Medicine in Madrid, Spain, and he obtained his MD from the Universidad Complutense School of Medicine. Dr. Pampaloni completed a residency in Nuclear Medicine at the San Carlos Hospital in Madrid, Spain, and he completed a residency in Nuclear Medicine at the University of Pennsylvania School of Medicine. Dr. Pampaloni was a postdoctoral fellow in Cardiovascular Nuclear Medicine at the David Geffen School of Medicine at UCLA, and he was a clinical research fellow in PET Cardiology at the Imperial College in London, England. Dr. Pampaloni joined the UCSF Nuclear Medicine Section as an Assistant Professor in 2009.

    Dr. Pampaloni has two main research interests: applications of molecular imaging into the cardiovascular field and oncology. He is interested in assessing the pathophysiological changes in the inflammatory process at the base of the coronary artery disease by non-invasive evaluation of endothelial function with positron emission tomography. He is particularly interested in developing a molecular imaging model to assess quantitatively the initial changes in the atherosclerotic process, which may help for an early, preclinical, diagnosis. As part of vascular biology characteristics, he is interested in applying new developed radioligands to target specific processes in the angiogenesis of cancer.

    Dr. Pampaloni is published broadly and has spoken to national and international audiences on multiple topics in nuclear medicine and molecular imaging, especially quantitative myocardial blood flow and ischemic cardiomyopathy. He led the Nuclear Medicine section for a decade, during which time he directed the opening of operations at Mission Bay Hospital, helped to bring multiple new imaging and treatment agents to clinical practice, and guided the professional development of numerous highly successful residents, fellows and faculty. He has served as PI and co-investigator on multiple clinical trials and received numerous accolades for his scientific presentations.

    Nuclear Medicine and Molecular Imaging and Theraputics

    Oncology, pediatric oncology, cardiovascular

    Professional Interests:
    Functional and multimodality imaging, development of oncology related radioligands, solid pediatric tumors, angiogenesis, myocardial and neoplastic response to hypoxia

    Education and Training:
    • Medical School: Universidad Complutense School of Medicine, Madrid, Spain
    • Internship: Imperial College, London - Cardiovascular Nuclear Medicine
    • Residency: San Carlos Hospital, Madrid, Spain - Nuclear Medicine
    • Residency: University of Pennsylvania School of Medicine - Nuclear Medicine
    • Fellowship: UCLA David Geffen School of Medicine Department of Medical and Molecular Pharmacology - Cardiovascular Nuclear Medicine
    • Fellowship: University of California, San Francisco Group for Leadership Collaborative Fellow
    • Clinical Research Fellow: Imperial College, London - Cardiovascular Nuclear Medicine
    • Doctor of Philosophy: Universidad Complutense School of Medicine, Madrid, Spain - Radiological Sciences
    • Colegio Oficial de Medicos, Madrid, Spain
    • Titulo de Especialista en Medicina Nuclear, Spain- Specialist Qualification in Nuclear Medicine
    • Specialist Register in the United Kingdom in Nuclear Medicine
    • General Medical Council, U.K.
    • Michigan Board of Medicine
    • Pennsylvania Controlled Substance Registration Certificate
    • Pennsylvania State Board of Medicine
    • California Medical Board
    • California Controlled Substance Registration Certificate (active)
    • American Board of Nuclear Medicine Board Certification
    • Certification Board in Nuclear Cardiology
    • Advanced Cardiac Life Support Certification (renewed)

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Academic Senate

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Pitfalls in [¹⁸F]FDG PET imaging in gynecological malignancies. Q J Nucl Med Mol Imaging. 2016 Jun; 60(2):124-38. Hernandez Pampaloni M, Facchetti L, Nardo L. PMID: 26937887.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Erratum to: Isolated right ventricular cardiac sarcoidosis demonstrated by (18)FDG positron emission tomography. J Nucl Cardiol. 2015 Feb; 22(1):221. Pampaloni MH, Nazer B, Botvinick E. PMID: 25342216.
      View in: PubMed   Mentions:    Fields:    
    3. PET/MRI radiotracer beyond ¹⁸F-FDG. PET Clin. 2014 Jul; 9(3):345-9. Pampaloni MH, Nardo L. PMID: 25030398.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. Isolated right ventricular cardiac sarcoidosis demonstrated by ¹⁸FDG positron emission tomography. J Nucl Cardiol. 2014 Jun; 21(3):652-4. Hernandez Pampaloni M, Nazer B, Nazar B, Botvinick E. PMID: 24429936.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    Miguel's Networks
    Concepts (25)
    Derived automatically from this person's publications.
    Co-Authors (2)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department